Literature DB >> 24551685

Mycobacterium fortuitum Peritonitis in a Patient on Continuous Ambulatory Peritoneal Dialysis (CAPD): A Case Report.

Jyoti Sangwan1, Sumit Lathwal2, Satish Kumar3, Deepak Juyal4.   

Abstract

Mycobacterium fortuitum, an environmental organism, is capable of producing a variety of clinical infections such as cutaneous infections, abscesses and nosocomial infections. Rarely, it has been a documented as a cause of peritonitis in patients receiving continuous ambulatory peritoneal dialysis (CAPD). Continuous Ambulatory Peritoneal dialysis (CAPD) is one of the treatment options which are used for patients with end-stage renal disease (ESRD). Although peritonitis rates have declined in parallel with advances in peritoneal dialysis (PD) technology, peritonitis remains a leading complication of CAPD and it is the major cause for transfer to other methods of dialysis. We are reporting a case of M. fortuitum peritonitis in a patient who was undergoing CAPD, which was successfully treated. This case emphasizes the importance of mycobacterial cultures in patients with CAPD-associated peritonitis, whose routine cultures may yield no organisms.

Entities:  

Keywords:  Acid fast bacilli; Dialysate culture, End-stage renal disease; Mycobacterium fortuitum; Peritonitis

Year:  2013        PMID: 24551685      PMCID: PMC3919311          DOI: 10.7860/JCDR/2013/6771.3803

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  10 in total

Review 1.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

Review 2.  Nosocomial outbreaks/pseudo-outbreaks caused by nontuberculous mycobacteria.

Authors:  R J Wallace; B A Brown; D E Griffith
Journal:  Annu Rev Microbiol       Date:  1998       Impact factor: 15.500

3.  Mycobacterium fortuitum--a human pathogen.

Authors:  W L Hand; J P Sanford
Journal:  Ann Intern Med       Date:  1970-12       Impact factor: 25.391

4.  Mycobacterium fortuitum peritonitis in two patients receiving continuous ambulatory peritoneal dialysis.

Authors:  G Vera; S Q Lew
Journal:  Am J Nephrol       Date:  1999       Impact factor: 3.754

5.  Sternal wound infections and endocarditis due to organisms of the Mycobacterium fortuitum complex.

Authors:  J N Kuritsky; M G Bullen; C V Broome; V A Silcox; R C Good; R J Wallace
Journal:  Ann Intern Med       Date:  1983-06       Impact factor: 25.391

6.  Mycobacteriosis in patients with chronic renal failure.

Authors:  E A Rutsky; S G Rostand
Journal:  Arch Intern Med       Date:  1980-01

Review 7.  Nontuberculous mycobacterial peritonitis during continuous ambulatory peritoneal dialysis: case report and review of diagnostic and therapeutic strategies.

Authors:  R B Dunmire; J A Breyer
Journal:  Am J Kidney Dis       Date:  1991-07       Impact factor: 8.860

Review 8.  Peritoneal dialysis-associated nontuberculous mycobacterium peritonitis: a systematic review of reported cases.

Authors:  Yan Song; Jianyong Wu; Huiling Yan; Jianghua Chen
Journal:  Nephrol Dial Transplant       Date:  2011-09-02       Impact factor: 5.992

Review 9.  Nontuberculous mycobacterial infections in continuous ambulatory peritoneal dialysis patients.

Authors:  R White; K Abreo; R Flanagan; M Gadallah; K Krane; M el-Shahawy; S Shakamuri; R McCoy
Journal:  Am J Kidney Dis       Date:  1993-10       Impact factor: 8.860

Review 10.  Mycobacterium fortuitum as a cause of peritoneal dialysis-associated peritonitis: case report and review of the literature.

Authors:  Simon H Jiang; Darren M Roberts; Andrew H Dawson; Meg Jardine
Journal:  BMC Nephrol       Date:  2012-06-08       Impact factor: 2.388

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.